LifeSci Capital Reaffirms Their Hold Rating on Rain Therapeutics (RAIN)

In a report released today, Sam Slutsky from LifeSci Capital maintained a Hold rating on Rain Therapeutics (RAIN – Research Report). The c...

Related Keywords

Guggenheim Michael Schmidt ,Sam Slutsky ,Rain Therapeutics Inc ,Lifesci Capital ,Brain Therapeutics ,Research Report ,Michael Schmidt ,Mizuho Securities ,Therapeutics Inc ,